Davis's Drug Guide
denileukin diftitox
General
High Alert Medication: This medication bears a heightened risk of causing significant patient harm when it is used in error.
Genetic Implications:
**Off Market Drug**
This medication is no longer available in the United States. Information provided here is for reference purposes only.
Pronunciation:
den-i-look-indif -ti-tox
To hear audio pronunciation of this topic, purchase a subscription or log in.Trade Name(s)
- Ontak
Ther. Class.
Pharm. Class.
cytotoxic proteins
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., et al. "Denileukin Diftitox." Davis's Drug Guide, 18th ed., F.A. Davis Company, 2023. The Washington Manual, www.unboundmedicine.com/washingtonmanual/view/Davis-Drug-Guide/51201/all/denileukin_diftitox.
Vallerand AHA, Sanoski CAC, Quiring CC. Denileukin diftitox. Davis's Drug Guide. F.A. Davis Company; 2023. https://www.unboundmedicine.com/washingtonmanual/view/Davis-Drug-Guide/51201/all/denileukin_diftitox. Accessed September 25, 2023.
Vallerand, A. H., Sanoski, C. A., & Quiring, C. (2023). Denileukin diftitox. In Davis's Drug Guide (18th ed.). F.A. Davis Company. https://www.unboundmedicine.com/washingtonmanual/view/Davis-Drug-Guide/51201/all/denileukin_diftitox
Vallerand AHA, Sanoski CAC, Quiring CC. Denileukin Diftitox [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2023. [cited 2023 September 25]. Available from: https://www.unboundmedicine.com/washingtonmanual/view/Davis-Drug-Guide/51201/all/denileukin_diftitox.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - denileukin diftitox
ID - 51201
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
AU - Quiring,Courtney,
BT - Davis's Drug Guide
UR - https://www.unboundmedicine.com/washingtonmanual/view/Davis-Drug-Guide/51201/all/denileukin_diftitox
PB - F.A. Davis Company
ET - 18
DB - The Washington Manual
DP - Unbound Medicine
ER -
